RECCHIA, FABIO ANASTASIO
 Distribuzione geografica
Continente #
NA - Nord America 13.658
EU - Europa 8.656
AS - Asia 1.254
Continente sconosciuto - Info sul continente non disponibili 84
OC - Oceania 21
SA - Sud America 11
AF - Africa 7
Totale 23.691
Nazione #
US - Stati Uniti d'America 13.429
GB - Regno Unito 3.239
UA - Ucraina 1.247
DK - Danimarca 1.118
IT - Italia 1.088
DE - Germania 910
CN - Cina 618
VN - Vietnam 443
SE - Svezia 410
CA - Canada 228
FI - Finlandia 203
IE - Irlanda 193
FR - Francia 113
HK - Hong Kong 101
EU - Europa 84
PL - Polonia 59
SG - Singapore 33
IN - India 24
CH - Svizzera 20
AU - Australia 13
NL - Olanda 13
BE - Belgio 10
BR - Brasile 10
JP - Giappone 10
PT - Portogallo 9
RO - Romania 9
NZ - Nuova Zelanda 8
ES - Italia 7
IR - Iran 6
KR - Corea 4
RU - Federazione Russa 4
GE - Georgia 3
TR - Turchia 3
CI - Costa d'Avorio 2
ID - Indonesia 2
NG - Nigeria 2
PK - Pakistan 2
RS - Serbia 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
MA - Marocco 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SD - Sudan 1
TH - Thailandia 1
UG - Uganda 1
Totale 23.691
Città #
Southend 2.638
Woodbridge 1.900
Ann Arbor 1.698
Chandler 1.252
Houston 1.134
Fairfield 793
San Mateo 790
Dearborn 657
Jacksonville 630
Falls Church 455
Seattle 440
Cambridge 384
Wilmington 382
Beijing 364
Wayne 330
Ashburn 305
Dong Ket 255
Stevenage 252
Portsmouth 219
Lawrence 208
Boardman 203
Pisa 182
Dublin 174
Ottawa 120
Redwood City 118
Montréal 91
Brooklyn 83
Guangzhou 74
San Diego 70
Old Bridge 69
Warsaw 51
Rome 42
Norwalk 40
Milan 34
London 30
Florence 22
Fremont 21
Foggia 18
Buti 17
Caserta 14
Selargius 13
Shenzhen 13
Augusta 12
Kunming 12
Paris 12
San Giuliano Terme 12
West Jordan 12
Hanover 11
Livorno 11
Helsinki 10
Provo 10
Nanjing 9
Osaka 9
Salerno 9
Chiswick 8
Genoa 8
Islington 8
Lyon 8
Mountain View 8
Philadelphia 8
Traverse City 8
Washington 8
Chicago 7
Freiburg im Breisgau 7
New York 7
Parma 7
Rimini 7
Siena 7
Ypsilanti 7
Bologna 6
Brussels 6
Dongguan 6
Melbourne 6
Nürnberg 6
Padova 6
San Antonio 6
Simi Valley 6
Gdynia 5
New Bedfont 5
Porto Ercole 5
Saint Louis 5
Santa Ana Heights 5
Sassari 5
Toronto 5
Auckland 4
Bagnolet 4
Berlin 4
Cerignola 4
Chengdu 4
Ferrara 4
Galati 4
Jinan 4
Kilburn 4
Leawood 4
Louisville 4
Menlo Park 4
Mykolayiv 4
Nanchang 4
Napoli 4
Noicattaro 4
Totale 16.974
Nome #
Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo. 243
3D CMR Mapping of Metabolism by Hyperpolarized 13C-Pyruvate in Ischemia–Reperfusion 183
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis 181
Multimodal molecular imaging system for pathway-specific reporter gene expression 173
Molecular Advances in Reporter Genes: The Need to Witness the Function of Stem Cells in Failing Heart in Vivo. 172
Real time cardiac metabolism assessed with hyperpolarized [1-13C] acetate in a large animal model 166
An Implantable ZigBee Ready Telemetric Platform For In Vivo Monitoring Of Physiological Parameters 163
DNP methods for cardiac metabolic imaging with hyperpolarized [1-13C]pyruvate large dose injection in pigs 163
Surgical Access and Stimulation of the Pig Pudendal Nerve to Restore Bladder Dysfunctions 156
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure 155
Proteomics-based network analysis characterizes biological processes and pathways activated by preconditioned mesenchymal stem cells in cardiac repair mechanisms 154
Cardiac adeno-associated virus 9-mediated delivery of nestin-640 prevents myocardial remodeling in a rodent model of post-ischemic heart failure 153
REGIONAL MAPPING OF MYOCARDIAL HIBERNATION PHENOTYPE IN IDIOPATHIC END-STAGE DILATED CARDIOMYOPATHY 153
Modulating Fatty Acid Oxidation in Heart Failure 153
Cardiovascular Molecular Imaging with Hyperpolarized [1-13C] acetate and [1-13C] pyruvate in middle size animal model 151
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5T cardiac MRI in a rat model of myocardial infarction 151
Placental stem cells pre-treated with hyaluronan-butyric-retinoic ester to cure infarcted pig hearts: a multimodal study. 143
Chronic inhibition of nitric oxide synthase alters cardiac substrate handling: underestimating changes in metabolism. 141
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure 140
Glucose-6-Phosphate Dehydrogenase Deficiency Increases Myocardial Redox Stress and Moderately Accelerates the Development of Heart Failure 140
Diverse protein kinase A-dependent myofilament protein phosphorylation in the background of regional contractile dysfunction in pacing-induced heart failure 139
Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs. 138
A Dose-Response Elevation in Hepatic Glucose Uptake is Paralleled by Liver Triglyceride Synthesis and Release. 136
Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. 136
Low HDL - high inflammatory markers in heart failure induced by high frequency pacing in minipigs. 135
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 134
Reduced cardiac NO production during pacing-induced heart failure 134
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs 132
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 132
Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. 131
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. 131
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. 131
Pathologic pulse pressure in isolated coronary artery bed augments flow in vivo despite constant ventricular workload 131
Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. 129
In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells 128
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. 128
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. 127
Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs. 126
Transthoracic Sensor for Noninvasive Assessment of Left Ventricular Contractility: Validation in A Minipig Model of Chronic Heart Failure. 126
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. 126
Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. 126
LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGS 125
Water-Dispersible Three-Dimensional LC-Nanoresonators 125
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. 124
Nestin is a key regulator of cardioprotection and nestin-640 gene therapy rescues infarcted myocardium 124
Nitric oxide-mediated arteriolar dilation after endothelial deformation 123
The rate of tension redevelopment is not modulated by sarcomere length in permeabilized human, murine and porcine cardiomyocytes. 123
Animal models of dilated cardiomyopathy for translational research. 123
Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs. 123
Segmental analysis of cardiac metabolism by hyperpolarized [1-13C] pyruvate: an in-vivo 3D MRI study in pigs 123
Short Interfering RNA-Mediated Knockdown Of Glucose-6-Phosphate Dehydrogenase Impairs Cardiac Contractile Performance and Efficiency in Conscious Dogs. 123
Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. 123
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. 122
Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. 122
Combined PET and Tagging-MRI reveal altered patterns of regional function and metabolism in ventricular dyssynchrony. 122
Evaluation of the expression of transcripts coding for CNP and for its specific receptor NPR-B by Real Time PCR in cardiac tissue of normal and heart failure animals 122
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. 122
Changes in cardiac metabolism produced by acute inhibition of NO synthase can be reversed by a long-acting NO donor 121
Amlodipine releases nitric oxide (NO) from coronary microvessels after pacing induced dilated cardiomyopathy. 121
Altered metabolic response to exercise in the eNOS knockout mice. 121
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture 121
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. 120
Modulation of caveolar trafficking of endothelial cells by diagnostic cardiac ultrasound. 120
Cardiac Metabolism in a Pig Model of Ischemia-Reperfusion by Cardiac Magnetic Resonance with Hyperpolarized 13C-Pyruvate 120
Early long‐term L‐T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats 120
Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca2+ mishandling or what else? 120
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats. 119
Selective alteration in cardiac glucose oxidation after prolonged inhibition of NO synthesis in conscious dogs 119
Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation 119
NO METABOLITES ACCUMULATE IN ERYTHROCYTES IN PROPORTION TO CARBON DIOXIDE AND BICARBONATE CONCENTRATION. 118
Acute vagal stimulation attenuates cardiac metabolic response to beta-adrenergic stress. 118
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications 118
Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy 118
Acetylation mediates Cx43 reduction caused by electrical stimulation 118
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. 117
Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart. 117
The activation of glucose 6-phosphate dehydrogenase as a source of substrate for NADPH oxidase in the failing heart 117
Cytokines are not a requisite part of the pathophysiology leading to cardiac decompensation. 116
Altered patterns of regional myocardial perfusion and metabolism in mechanical dyssynchrony induced by chronic unipolar left ventricular pacing. 116
Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs 116
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. 116
CELL-TO-CELL VARIABILITY IN TROPONIN I PHOSPHORYLATION IN A PORCINE MODEL OF PACING-INDUCED HEART FAILURE 116
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy 116
Potent cardioprotective effect exerted by AAV-VEGF-B in small and large animal models of myocardial infarction 115
Increased myocardial glucose oxidation in severe heart failure despite reduced pyruvate dehydrogenase activity 115
Tumor necrosis factor- and interleukin-6 do not increase during pacing-induced dilated cardiomyopathy. 115
Nitric oxide modifies metabolic but not perfusion pressure related coronary flow regulation in isolated blood perfused canine ventricles 115
Coronary nitric oxide production controls cardiac substrate metabolism during pregnancy in the dog. 114
New therapies for the failing heart: trans-genes versus trans-cells. 114
AAV-Mediated Delivery of VEGF-B Preserves Viability and Cardiac Function Following Myocardial Infarction through a Direct Effect on Cardiomyocyte Survival and Contractility 114
Nitric oxide metabolites accumulation in erythrocytes is proportional to the bicarbonate concentration. 114
Minimal role of nitric oxide in basal coronary flow regulation and cardiac energetics of blood-perfused isolated canine heart. 113
Overview of ventilator-induced lung injury mechanisms 113
Pre-treatment of human mesenchymal stem cells with a chemical inductor of cardiogenesis increases their effects on regional myocardial function in a swine model of myocardial infarction. 113
Acute NO synthase inhibition profoundly alters myocardial oxidation of free fatty acids and glucose in conscious dogs 113
Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters myocardial substrate metabolism in conscious dogs: role of nitric oxide. 112
Experimental approaches to cardiac imaging with hyperpolarized [1-13c]pyruvate: a feasibility study in rats with a 3T clincal scanner 112
The role of C-type natriuretic peptide in the heart: study in an experimental model of pacing-induced heart failure 112
Pronounced reduction in left-ventricular diastolic compliance, work and mechanical efficiency after prolonged inhibition of nitric oxide synthesis in conscious dogs 112
Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor alpha in pacing-induced heart failure 111
Totale 12.964
Categoria #
all - tutte 90.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019116 0 0 0 0 0 0 0 0 0 20 22 74
2019/20202.968 50 45 213 88 762 451 563 92 312 41 54 297
2020/20214.555 156 651 312 338 433 578 291 197 278 274 433 614
2021/20223.340 170 615 419 278 65 61 315 592 162 323 81 259
2022/20232.877 233 126 48 605 366 469 36 235 481 69 110 99
2023/2024917 151 66 203 58 65 161 133 31 13 36 0 0
Totale 23.865